ArticleAntimicrobial agents and chemotherapy2011

Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.

A Louie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.